Algert Global LLC Takes $266,000 Position in Azenta, Inc. (NASDAQ:AZTA)

Algert Global LLC bought a new stake in Azenta, Inc. (NASDAQ:AZTA) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 5,058 shares of the company’s stock, valued at approximately $266,000.

Other large investors also recently bought and sold shares of the company. Hantz Financial Services Inc. purchased a new position in shares of Azenta in the 2nd quarter worth $30,000. Benjamin F. Edwards & Company Inc. purchased a new position in Azenta in the first quarter worth about $38,000. BI Asset Management Fondsmaeglerselskab A S bought a new stake in Azenta during the first quarter worth approximately $49,000. Lazard Asset Management LLC purchased a new stake in Azenta during the first quarter valued at approximately $130,000. Finally, Acadian Asset Management LLC lifted its stake in shares of Azenta by 24.7% in the 1st quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock valued at $143,000 after purchasing an additional 471 shares during the last quarter. Institutional investors own 99.08% of the company’s stock.

Azenta Stock Performance

Shares of AZTA stock opened at $44.56 on Thursday. The stock has a 50 day moving average price of $49.76 and a 200 day moving average price of $52.64. Azenta, Inc. has a 52-week low of $43.71 and a 52-week high of $69.16. The firm has a market capitalization of $2.40 billion, a P/E ratio of -16.44 and a beta of 1.47.

Azenta (NASDAQ:AZTA) last issued its earnings results on Tuesday, August 6th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.09. The firm had revenue of $173.00 million during the quarter, compared to analyst estimates of $166.14 million. Azenta had a negative net margin of 23.66% and a positive return on equity of 0.89%. The business’s revenue was up 4.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.13 earnings per share. As a group, sell-side analysts forecast that Azenta, Inc. will post 0.33 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on AZTA. Evercore ISI cut their target price on Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 1st. Needham & Company LLC reissued a “buy” rating and issued a $69.00 target price on shares of Azenta in a research note on Wednesday, August 7th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $66.40.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.